Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Absci Corp (ABSI)

Absci Corp (ABSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 327,914
  • Shares Outstanding, K 114,856
  • Annual Sales, $ 5,720 K
  • Annual Income, $ -110,570 K
  • EBIT $ -90 M
  • EBITDA $ -55 M
  • 60-Month Beta 2.04
  • Price/Sales 80.09
  • Price/Cash Flow N/A
  • Price/Book 1.82

Options Overview Details

View History
  • Implied Volatility 162.52% ( +14.85%)
  • Historical Volatility 132.76%
  • IV Percentile 90%
  • IV Rank 36.11%
  • IV High 383.11% on 09/12/24
  • IV Low 37.86% on 10/07/24
  • Put/Call Vol Ratio 0.14
  • Today's Volume 1,585
  • Volume Avg (30-Day) 1,261
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 22,065
  • Open Int (30-Day) 17,017

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.23
  • Number of Estimates 4
  • High Estimate -0.22
  • Low Estimate -0.25
  • Prior Year -0.25
  • Growth Rate Est. (year over year) +8.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.55 +12.18%
on 12/31/24
4.56 -37.39%
on 12/11/24
-1.16 (-28.98%)
since 12/10/24
3-Month
2.45 +16.53%
on 11/19/24
4.56 -37.39%
on 12/11/24
-0.93 (-24.67%)
since 10/10/24
52-Week
2.45 +16.53%
on 11/19/24
6.72 -57.51%
on 04/09/24
-1.55 (-35.11%)
since 01/10/24

Most Recent Stories

More News
Small-Cap Biotech Absci Draws Heavy Attention On $20M AMD Investment Pledge, Retail's Bullish Despite Pre-Market Dip

The investment reportedly marks AMD’s entry into life sciences, leveraging its AI chips for drug discovery.

AMD : 116.04 (-4.76%)
ABSI : 2.86 (-11.34%)
Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

ABSI : 2.86 (-11.34%)
Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

ABSI : 2.86 (-11.34%)
Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

ABSI : 2.86 (-11.34%)
Absci to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

ABSI : 2.86 (-11.34%)
Absci Corporation Advances Internal Pipeline with New Drug Candidate ABS-201 for Androgenic Alopecia and Breakthroughs in AI-Designed Antibodies

Absci announces drug candidate ABS-201 for androgenic alopecia and breakthroughs in antibody design using its AI platform.Quiver AI SummaryAbsci Corporation has announced significant advancements in its...

ABSI : 2.86 (-11.34%)
Industry Survey Reveals Overwhelming Support for AI-Powered Healthcare

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – The healthcare sector is undergoing a profound transformation, propelled by the rapid evolution of artificial...

TWST : 43.60 (-3.37%)
AVAI : 0.5100 (-6.56%)
ABSI : 2.86 (-11.34%)
RXRX : 6.88 (-5.23%)
MDAI : 2.20 (+0.92%)
RHHBY : 36.4600 (-0.65%)
Absci Highlights Progress and Updates Across Proprietary Pipeline and Leading AI Platform at 2024 R&D Day

ABSI : 2.86 (-11.34%)
Absci to Participate in the 36th Annual Piper Sandler Healthcare Conference

ABSI : 2.86 (-11.34%)
AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care

/CNW/ -- Healthcare is undergoing a transformative shift, with new technologies enabling breakthroughs that were once unimaginable. According to the World...

AVAI : 0.5100 (-6.56%)
TWST : 43.60 (-3.37%)
SYK : 365.66 (+0.43%)
ABSI : 2.86 (-11.34%)
RDNT : 68.78 (-4.80%)

Business Summary

Absci Corporation is the AI-powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. The company's Creation(TM) Platform involved in discovery of novel biotherapeutic drug candidates and generation of the cell lines to manufacture them in a single...

See More

Key Turning Points

3rd Resistance Point 3.31
2nd Resistance Point 3.20
1st Resistance Point 3.03
Last Price 2.86
1st Support Level 2.75
2nd Support Level 2.64
3rd Support Level 2.47

See More

52-Week High 6.72
Fibonacci 61.8% 5.09
Fibonacci 50% 4.59
Fibonacci 38.2% 4.08
Last Price 2.86
52-Week Low 2.45

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar